CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 106 enrolled
Drug / intervention
Waveform-confirmed loss-of-resistanceprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02479763
NCT02479763Phase 3Completed
CompareCT.gov

A Randomized Comparison Between Conventional and Waveform-Confirmed Loss-of-Resistance for Thoracic Epidural Blocks

Montreal General Hospital·interventional·Posted Jun 24, 2015·Updated Feb 22, 2016

In Brief

A Phase 3 clinical trial evaluating Waveform-confirmed loss-of-resistance for Anesthesia. Completed, enrolled 106 participants across 2 sites in 2 countries.

Detailed Summary

In the investigators' institution, the failure rate for thoracic epidural blocks is 23.1%. This stems from the prevalence of trainee operators coupled with the non-specific nature of loss-of-resistance. In the current randomized trial, we will set out to compare conventional and epidural waveform analysis-confirmed loss-of-resistance. The investigators' research hypothesis is that loss-of-resistance combined with epidural waveform analysis will decrease the failure rate of thoracic epidural blocks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia
CountriesCanada, Thailand
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 24, 2015
Enrollment StartJun 1, 2015
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.0 years ago

Interventions

Waveform-confirmed loss-of-resistanceprocedure

Using waveform analysis to confirm thoracic epidural space